
AUDIT SERIES: BATTERY & CELL STRATEGY (1/4) 🔋📉
Billions in investment meet cooling demand: Why European cell manufacturing is heading toward a structural capacity paradox.
However, the current market reality—viewed through the lens of Marketing System Architecture (MSA)—demands a rigorous reassessment:
▪️ Overcapacity & Price Erosion: Global supply of battery cells significantly outstrips current demand. Chinese market leaders are driving down the price per kilowatt-hour to levels that new European facilities struggle to match.
▪️ The Shift to LFP Technology: While European cell factories were primarily designed for more expensive NMC (nickel-manganese-cobalt) chemistry, the mass market now demands cost-effective LFP (lithium-iron-phosphate) cells.
▪️ The Utilization Trap: A gigafactory only becomes economically viable at a capacity utilization rate of 80% to 85%. If the ramp-up is throttled, fixed costs per unit produced skyrocket.
Applying the Marketing System Architecture (MSA) framework reveals that competitiveness is not determined by technology alone, but rather by the synchronization between market velocity and capital commitment.

AUDIT SERIES: BATTERY & CELL STRATEGY (2/4) 🔗🏭
An ecosystem of partnerships—but who bears the risk when purchase volumes decline?
▪️ Cathode materials (e.g., Ionway with Umicore): Establishing dedicated European supply chains requires billions in upfront investment—the amortization of which is directly tied to high cell production volumes.
▪️ Technology and volume partners (Gotion High-Tech, QuantumScape): While these collaborations secure access to LFP expertise and solid-state battery research, they also highlight an ongoing technological reliance on external partners.
▪️ Raw material offtake agreements (e.g., lithium projects): Long-term purchase contracts provide a hedge against price increases, but become a rigid financial burden if production is scaled back.

AUDIT SERIES: BATTERY & CELL STRATEGY (3/4) 🌍⚖️
Salzgitter, Valencia, St. Thomas – and the implications for traditional component plants.

AUDIT SERIES: BATTERY & CELL STRATEGY (4/4) 🏛️📋
Ahead of critical negotiations with the Works Council: The consequences that the proposed package of measures will impose on the workforce and suppliers.
▪️ "Make-or-Buy" for battery cells: How many cells will VW actually continue to manufacture in-house in Europe—and at what point will cost considerations necessitate sourcing them from Asian partners? Any cutbacks at the Salzgitter site directly limit the future prospects of the workforce.
▪️ Production volume commitments vs. capacity reduction: The Works Council is demanding binding capacity utilization guarantees for German plants, while the Executive Board intends to use its package of measures to eliminate structural overcapacity.
▪️ Labor costs and collective bargaining: Wage freezes, adjustments to working-time models, bonus cuts, and early termination agreements are being used by the Executive Board as levers to offset shortfalls in cost coverage during the industry's transformation.
▪️ The domino effect on suppliers: Any shift or reduction in cell and platform volumes hits the entire value chain—from mechanical engineering firms to small and medium-sized enterprises (SMEs)—with full force and without any contractual safeguards.
📄 Final white paper to follow: I will soon be consolidating all four modules—including the complete location and risk matrix—into a concise executive white paper, which will be available for download.
